ARTICLES BY THIS AUTHOR

• 9/26/2020

  COVID-19 causing stress, depression and obsessive behaviour: Alberta survey

• 9/26/2020

  Sick benefits for physicians in time of COVID-19

• 9/24/2020

  B.C.'s Dr. Henry thanks supporters after revealing threats over COVID-19 measures

• 9/24/2020

  Alberta's top health official says province is not in a second wave of COVID-19

• 9/24/2020

  Ontario making bars and restaurants close earlier, shuts down strip clubs

• 9/24/2020

  The September issue is now out!

  The September issue of <em>Pharmacy Practice + Business </em>is now available to read online. Check it out for updated Drug News, clinical and practice features and more.
• 9/24/2020

  New details emerge about COVID-19 testing in Ontario

  Details, including fees, how to test and who to prioritize are quickly being released by both the OPA and the OCP.
• 9/23/2020

  Emgality (galcanezumab) now indicated to reduce cluster headache frequency

  CGRP binding antibody is first drug approved by Health Canada to help prevent episodic cluster headaches
• 9/23/2020

  The before and after of our lives

• 9/23/2020

  Key clinical guidelines and statements – June to August, 2020

  Most recent updates include resources on cannabis in adolescents, corticosteroids for bronchopulmonary dysplasia in preterm infants, COVID-19, dementia, diabetes-low carbohydrate diets, influenza 2020/21, naloxone, obesity, pulmonary arterial hypertension, syncope, ventricular tachycardia/fibrillation.